t(3;12)(q26;p13) ETV6/MECOM
t(3;12)(q26;p13) ETV6/EVI1
2014-04-01 Etienne De Braekeleer , Etienne De Braekeleer , Etienne De Braekeleer
Affiliation
1.Cytogenetics Laboratory, Faculty of Medicine, University of Brest, France
Clinics and Pathology
Phenotype stem cell origin
Multilineage involvement; MDS--> M0, M2, M4, M7.
Epidemiology
46 cases described so far; sex ratio: 29M/16F (1 unknown); age: 2.5-87 yrs (med: 49 yrs), unknown age for 10 cases.
Cytology
Dysplasia of megakaryocytes, multilineage involvement.
Survival curve (21 patients, Mean: 12 mths, Median: 10 mths).
Prognosis
See survival curve above.
Cytogenetics
Cytogenetics molecular
Heterogeneity of the EVI1 breakpoints, as evidenced by the Cytocell Aquarius EVI1 Breakapart probe. The EVI1 Breakapart probe contains three probes: a probe labeled in Aqua of 562 kb in size centromeric to the EVI1 gene, a probe labeled in Spectrum Green of 181 kb covering EVI1 and its flanking regions and a probe labeled in Spectrum Orange of 124 kb telomeric of the EVI1 gene (telomeric of MYNN and covering LRRC34).
Additional anomalies
Sole anomaly in 22 cases. Additional anomalies: t(9;22)(q34;q11) in 5 cases, -7/del(7q) in 11 cases, del(5q) in 2 cases, others in 6 cases.
Genes Involved and Proteins
Gene name
MECOM (Ecotropic Viral Integration Site 1 (EVI1) and Myelodysplastic Syndrome 1 (MDS1-EVI1)
Location
3q26.2
Note
Alias EVI1
Dna rna description
MECOM is a "complex entity" made of two genes, EVI1 and MDS1. EVI1 has 16 exons, of which 14 are coding, the start ATG codons being in exon 3. MDS1 has 4 exons, exon 4 being located in the vicinity of exon 1 of EVI1. Splicing of the second exon of MDS1 to the second exon of EVI1 leads to a MDS1-EVI1 mRNA.
Protein description
EVI1 contains two domains of seven and three zinc finger motifs separated by a repression domain and an acidic domain at its C-terminus.
Gene name
ETV6 (ets variant 6)
Location
12p13.2
Note
The ETV6 gene encodes a transcription factor frequently rearranged in myeloid and lymphoid leukemias.
Dna rna description
The ETV6 gene spans a region of less than 250 kb at band 12p13.1 and consists of 8 exons. There are two start codons, one (exon 1a starting at codon 1) located at the beginning of the gene and another alternative (exon 1b starting at codon 43) upstream of exon 3.
Protein description
The ETV6 protein (452 amino acids) contains two major domains, the HLH (helix-loop-helix) and ETS domains. The HLH domain, also referred to as the pointed or sterile alpha motif domain, is encoded by exons 3 and 4 and functions as a homo-oligodimerization domain. The ETS domain, encoded by exons 6 through 8, is responsible for sequence specific DNA-binding and protein-protein interaction.
Result of the Chromosomal Anomaly
Description
Two mechanisms for generating the fusion gene, depending upon the involvement of the MDS1 gene.
Transcript
1) In-frame transcript consisting of the first two exons of ETV6 fused to MDS1 sequences, which in turn is fused to the second exon of the EVI1 gene.
2) Out-of-frame fusion by direct fusion between exon 2 of ETV6 and exon 2 of EVI1, but keeping the open reading frame of EVI1 intact.
2) Out-of-frame fusion by direct fusion between exon 2 of ETV6 and exon 2 of EVI1, but keeping the open reading frame of EVI1 intact.
Schematic diagram of the ETV6, EVI1, MDS1, MDS1-EVI1, ETV6-EVI1 and ETV6-MDS1-EVI1 proteins.
Description
ETV6 contributes no known functional domain to the predicted chimeric protein but functional domains of EVI1 are retained.
Oncogenesis
The oncogenic potential of the translocation could be the result of the ETV6 promoter driving the transcription of EVI1. Because the ETV6 promoter is active in hematopoietic cells, this would result in inappropriate expression of the transcription factor EVI1.
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36916780 | 2023 | RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification. | 54 |
| 31648321 | 2019 | Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. | 54 |
| 38662349 | 2024 | High throughput screening aids clinical decision-making in refractory acute myeloid leukaemia. | 33 |
| 38405662 | 2024 | The ETV6-MECOM fusion protein promotes EMT-related properties by repressing the transactivation activity of E-cadherin promoter in K562 leukemia cells. | 29 |
| 28182364 | 2017 | A Rare Case of ETV6/MECOM Rearrangement in Therapy-Related Acute Myeloid Leukemia with t(3;12) and Monosomy 7. | 0 |
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 17341266 | 2007 | An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies. | Bobadilla D et al |
| 8643684 | 1996 | Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. | Fears S et al |
| 8168137 | 1994 | Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. | Golub TR et al |
| 22162288 | 2012 | ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events. | Haferlach C et al |
| 11835339 | 2002 | Expression of the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13). | Nakamura Y et al |
| 9447815 | 1997 | The EVI1 gene in myeloid leukemia. | Nucifora G et al |
| 21872826 | 2011 | Frequent EVI1 translocations in myeloid blast crisis CML that evolves through tyrosine kinase inhibitors. | Paquette RL et al |
| 9044825 | 1997 | Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. | Peeters P et al |
| 16342172 | 2006 | EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements. | Poppe B et al |
| 8695816 | 1996 | Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. | Raynaud SD et al |
| 8547101 | 1995 | Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study. | Secker-Walker LM et al |
| 9067573 | 1997 | The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. | Soderholm J et al |
| 12555218 | 2003 | Acute myelogenous leukemia with the t(3;12)(q26;p13) translocation: case report and review of the literature. | Voutsadakis IA et al |
| 17507183 | 2007 | The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. | Wieser R et al |
| 11021761 | 2000 | Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1. | van de Loosdrecht AA et al |
Summary
Fusion gene
ETV6/MECOM ETV6 (12p13.2) MECOM (3q26.2) M t(3;12)(q26;p13)|ETV6/MECOM ETV6 (12p13.2) MECOM (3q26.2) TIC
Note
Only a few cases were shown to involve a ETV6/MECOM fusion by FISH or RT-PCR. In other cases, only MECOM or ETV6 was shown to be rearranged by FISH. Over-expression of MECOM/EVI1 was found in other cases. Finally, no cytogenetic or molecular analysis was performed in a few cases.
t(3;12)(q26;p13) ETV6/MECOM left: G-banding - Courtesy Jean-Luc Lai and Alain Vanderhaegen; right: R-banded karyotype (top) and FISH using the double break apart probes MECOM/3q26 (Metasystems)(bottom left) and ETV6 /12p13 (Abbott)(bottom right). Courtesy Karolien Beel, Peter Meeus and Lucienne Michaux, CME, UZ Leuven.
Citation
Etienne De Braekeleer ; Etienne De Braekeleer ; Etienne De Braekeleer
t(3;12)(q26;p13) ETV6/MECOM
t(3;12)(q26;p13) ETV6/EVI1
Atlas Genet Cytogenet Oncol Haematol. 2014-04-01
Online version: http://atlasgeneticsoncology.org/haematological/1008/t(3;12)(q26;p13)-etv6-mecom-br-t(3;12)(q26;p13)-etv6-evi1
Historical Card
1997-09-01 t(3;12)(q26;p13) ETV6/MECOM
t(3;12)(q26;p13) ETV6/EVI1 by François Desangles
Affiliation
